Evidence-Based Medicine Guidelines
Neoadjuvant chemotherapy for invasive bladder cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neoadjuvant Chemotherapy for Invasive Bladder Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456441/all/Neoadjuvant_chemotherapy_for_invasive_bladder_cancer.
Neoadjuvant chemotherapy for invasive bladder cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456441/all/Neoadjuvant_chemotherapy_for_invasive_bladder_cancer. Accessed July 22, 2025.
Neoadjuvant chemotherapy for invasive bladder cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456441/all/Neoadjuvant_chemotherapy_for_invasive_bladder_cancer
Neoadjuvant Chemotherapy for Invasive Bladder Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 July 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456441/all/Neoadjuvant_chemotherapy_for_invasive_bladder_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neoadjuvant chemotherapy for invasive bladder cancer
ID - 456441
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456441/all/Neoadjuvant_chemotherapy_for_invasive_bladder_cancer
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
